Literature DB >> 20090520

Transcatheter aortic-valve replacement: a cardiac surgeon and cardiologist team perspective.

Marc Ruel1, Marino Labinaz.   

Abstract

PURPOSE OF REVIEW: Transcatheter aortic-valve implantation is a promising new treatment modality for patients with aortic-valve disease, where it may revolutionize the treatment of elderly and high-risk patients. RECENT
FINDINGS: The two devices currently available, the Edwards Sapien valve and the Medtronic CoreValve system, are presented. With a focus on the CoreValve, we describe the indications, contraindications, procedural technique, cardiologist and heart surgeon team dynamics, and special considerations in patients with concomitant cardiopulmonary disease, peripheral arterial disease, low gradient aortic stenosis, and previous bioprosthetic aortic-valve replacement.
CONCLUSION: We make a case for judicious team-based adoption of these new technologies and emphasize the need for evidence-based and health economics data. We believe that the above will enable determining the therapeutic niche of these modalities amongst the excellent results of conventional aortic-valve replacement surgery.

Entities:  

Mesh:

Year:  2010        PMID: 20090520     DOI: 10.1097/HCO.0b013e328335fff4

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  2 in total

1.  Teamwork, communication, formula-one racing and the outcomes of cardiac surgery.

Authors:  Alan F Merry; Jennifer Weller; Simon J Mitchell
Journal:  J Extra Corpor Technol       Date:  2014-03

2.  Apico-Aortic Conduit for severe aortic stenosis: Technique, applications, and systematic review.

Authors:  Elsayed Elmistekawy; Harry Lapierre; Thierry Mesana; Marc Ruel
Journal:  J Saudi Heart Assoc       Date:  2010-07-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.